CIBC Asset Management Inc Grows Stock Holdings in Tilray Inc (NASDAQ:TLRY)

CIBC Asset Management Inc grew its holdings in Tilray Inc (NASDAQ:TLRY) by 11.4% during the 4th quarter, Holdings Channel reports. The fund owned 1,011,740 shares of the company’s stock after purchasing an additional 103,642 shares during the period. CIBC Asset Management Inc’s holdings in Tilray were worth $1,335,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in TLRY. Creative Planning boosted its holdings in shares of Tilray by 36.6% in the 3rd quarter. Creative Planning now owns 141,921 shares of the company’s stock valued at $250,000 after acquiring an additional 38,054 shares during the last quarter. International Assets Investment Management LLC boosted its holdings in shares of Tilray by 335.3% in the 3rd quarter. International Assets Investment Management LLC now owns 23,639 shares of the company’s stock valued at $42,000 after acquiring an additional 18,208 shares during the last quarter. Capital Management Associates Inc purchased a new stake in shares of Tilray in the 3rd quarter valued at $45,000. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Tilray by 22.6% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 39,819 shares of the company’s stock valued at $70,000 after acquiring an additional 7,339 shares during the last quarter. Finally, Pallas Capital Advisors LLC boosted its holdings in shares of Tilray by 58.1% in the 3rd quarter. Pallas Capital Advisors LLC now owns 31,646 shares of the company’s stock valued at $52,000 after acquiring an additional 11,632 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Stock Performance

Shares of NASDAQ TLRY opened at $0.95 on Friday. The company’s fifty day moving average price is $1.17 and its 200 day moving average price is $1.46. Tilray Inc has a 1 year low of $0.83 and a 1 year high of $2.97. The company has a market capitalization of $892.18 million, a PE ratio of -3.17 and a beta of 2.07. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The company had revenue of $210.90 million for the quarter, compared to analysts’ expectations of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, research analysts predict that Tilray Inc will post -0.2 earnings per share for the current year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group increased their price target on shares of Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Tilray currently has an average rating of “Hold” and an average target price of $2.70.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.